...
首页> 外文期刊>Molecular Immunology >Immuno-informatics based approaches to design a novel multi epitope-based vaccine for immune response reinforcement against Leptospirosis
【24h】

Immuno-informatics based approaches to design a novel multi epitope-based vaccine for immune response reinforcement against Leptospirosis

机译:基于免疫信息学的设计方法,用于设计一种用于免疫反应增强对钩端螺旋体病的影响

获取原文
获取原文并翻译 | 示例
           

摘要

Leptospirosis is known as a zoonotic disease of global importance originated from infection with the spirochete bacterium Leptospira. Although several leptospirosis vaccines have been tested, the vaccination is-relatively unsuccessful in clinical application despite decades of research. Therefore, this study was conducted to construct a novel multi-epitope based vaccine against leptospirosis by using Hapl, LigA, LAg42, SphH and HSP58 antigens. T cell and IFN gamma epitopes were predicted from these antigens. In addition, to induce strong CD4 helper T lymphocytes (HTLs) responses, Pan HLA DR-binding epitope (PADRE) and helper epitopes selected from Tetanus toxin fragment C (TITrC) were applied. Moreover, for boosting immune response, Heparin-Binding Hemagglutinin (HBHA), a novel TLR4 agonist was added to the construct as an adjuvant. Finally, selected epitopes were linked together using EAAAK, GPGPG, AAY and HEYGAEALERAG linkers. Based on the predicted epitopes, a multi-epitope vaccine was construct with 490 amino acids. Physico-chemical properties, secondary and tertiary structures, stability, intrinsic protein disorder, solubility, and allergenicity of this vaccine construct were assessed by applying immunoinformatics analyses. A soluble, and non-allergic protein with a molecular weight of 53.476 kDa was obtained. Further analyses validated the stability of the chimeric protein and the predicted epitopes in the chimeric vaccine indicated strong potential to induce B-cell and T-cell mediated immune response. Therefore, immunoinformatics analysis showed that the modeled multi-epitope vaccine can properly stimulate the both T and B cells immune responses and could potentially be used for prophylactic or therapeutic usages.
机译:钩端螺旋体病症被称为全球性疾病的一种人群疾病,起源于螺旋细菌睑螺旋状菌感染。尽管已经测试了几种钩端螺旋体病疫苗,但在几十年的研究中,临床应用中的疫苗接种是相对不成功的。因此,通过使用HAPL,LIGA,LAG42,SPHH和HSP58抗原来进行该研究以构建针对钩螺旋体测量的新型多表次疫苗。从这些抗原预测T细胞和IFNγ表位。此外,为了诱导强的CD4辅助T淋巴细胞(HTLS)反应,施加从破伤风毒素片段C(滴度)中选择的PAN HLA DR结合表位(PADRE)和辅助表位。此外,为了提高免疫应答,将肝素结合血凝素(HBHA),将新的TLR4激动剂作为佐剂加入构建体中。最后,选择的表位使用EAAAK,GPGPG,Aay和Heygaealerag接头连接在一起。基于预测的表位,用490个氨基酸构建一种多表位疫苗。通过施加免疫信息分析来评估该疫苗构建体的次级和三级结构,仲裁和三级结构,稳定性,内在蛋白质障碍,溶解度和过敏性。获得分子量为53.476kDa的可溶性和非过敏性蛋白质。进一步分析验证了嵌合蛋白质的稳定性和嵌合疫苗中的预测表位表明诱导B细胞和T细胞介导的免疫应答的强潜力。因此,免疫信息分析表明,模拟的多表位疫苗可以适当地刺激T和B细胞免疫应答,并且可能用于预防或治疗用法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号